- Home
- NERV vs ACXP Comparison
NERV vs ACXP Comparison
Compare NERV & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- ACXP
- Stock Information
- Founded
- NERV 2007
- ACXP 2017
- Country
- NERV United States
- ACXP United States
- Employees
- NERV N/A
- ACXP N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- NERV Health Care
- ACXP Health Care
- Exchange
- NERV Nasdaq
- ACXP Nasdaq
- Market Cap
- NERV 10.7M
- ACXP 9.0M
- IPO Year
- NERV 2014
- ACXP 2021
- Fundamental
- Price
- NERV $1.61
- ACXP $0.36
- Analyst Decision
- NERV Hold
- ACXP Strong Buy
- Analyst Count
- NERV 1
- ACXP 1
- Target Price
- NERV $5.00
- ACXP $12.00
- AVG Volume (30 Days)
- NERV 15.1K
- ACXP 235.2K
- Earning Date
- NERV 04-30-2025
- ACXP 05-13-2025
- Dividend Yield
- NERV N/A
- ACXP N/A
- EPS Growth
- NERV N/A
- ACXP N/A
- EPS
- NERV 0.19
- ACXP N/A
- Revenue
- NERV N/A
- ACXP N/A
- Revenue This Year
- NERV N/A
- ACXP N/A
- Revenue Next Year
- NERV N/A
- ACXP N/A
- P/E Ratio
- NERV $8.95
- ACXP N/A
- Revenue Growth
- NERV N/A
- ACXP N/A
- 52 Week Low
- NERV $1.42
- ACXP $0.35
- 52 Week High
- NERV $3.69
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- NERV 41.00
- ACXP 26.25
- Support Level
- NERV $1.54
- ACXP $0.40
- Resistance Level
- NERV $1.89
- ACXP $0.45
- Average True Range (ATR)
- NERV 0.11
- ACXP 0.03
- MACD
- NERV 0.00
- ACXP 0.00
- Stochastic Oscillator
- NERV 22.68
- ACXP 6.21
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.